New York Yankees say Legionella bacteria found in stadium cooling tower not linked to outbreak
On Sept. 14, 2026, bacteria that cause potentially fatal Legionnaires’ disease were found in a Yankee Stadium cooling…
-
-
Michael J. Fox Foundation for Parkinson’s Research Receives Lasker~Bloomberg Public Service Award
On Sept. 10, 2026, Lasker~Bloomberg Public Service Award honors Michael J. Fox (Michael J. Fox Foundation for Parkinson’s…
-
Tom Golisano Commits $225 Million to Six Additional Children’s Hospitals, Expanding Golisano Children’s Alliance to 21 Members Nationwide
On Sept. 10, 2026, philanthropist and entrepreneur Tom Golisano announced a $225 million investment in six children’s hospitals,…
-
Lasker~DeBakey Clinical Medical Research Award Recognizes hemophilia A Treatment
On Sept. 9, 2026, the Albert Lasker~DeBakey Clinical Medical Research Award honored three scientists for inventing a bispecific…
-
Emmanuel Mignot and Masashi Yanagisawa Receive Albert Lasker Basic Medical Research Award
On Sept. 9, 2026, the Albert Lasker Basic Medical Research Award honors two physician scientists for the identification…
-
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
On Aug. 27, 2026, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) has approved…
-
Biotechnology | Disease | FDA
Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis
On Aug. 27, 2026, Roivant announced that the U.S. Food and Drug Administration (FDA) has approved LISRAYA™ (brepocitinib)…
-
Bill Ackman donates $400 Million from Pershing Square to fund new brain institute
On Aug. 20, 2026, hedge fund billionaire Bill Ackman and his wife, Neri Oxman, announced the were donating…
-
First complete songbird genome reveals hidden biology
On Aug. 6, 2026, scientists at Rockefeller University’s Jarvis lab announced that they have assembled the first fully…
-
Family History Increases Cancer Risk in BRCA-Tested Patients
On Jul. 30, 2026, a study led by Cedars-Sinai Health Sciences University investigators found that women who test…
-
Biotechnology | Disease | HIV | Therapeutics | WHO
Merck licenses experimental HIV pill to generic makers in 129 countries
On Jul. 24, 2026, Merck announced it has signed seven voluntary licensing agreements with generic drug manufacturers to…
-
Feinstein Institutes technology that restores movement and sensation after paralysis Published in Nature Medicine
On Jul. 16, 2026, the Feinstein Institutes for Medical Research announced findings featured in Nature Medicine demonstrating that…
-
NYC Health Department Releases List of Buildings Ordered To Clean and Disinfect Their Cooling Towers for Legionnaires Disease
On Jul. 10, 2026, The NYC Health Department released, for the first time, a preliminary list of 31…
-
Nanoparticles sneak antibodies into cells to inhibit cancer, inflammation
On Jun. 23. 2026, scientists at Cornell University announce discovering a delivery system that uses lipid nanoparticles to…
-
Cancer-on-a-chip pioneer Chen Weiqiang returns to China from New York University
On Jun. 21, 2026, Chen Weiqiang, formerly a tenured professor of mechanical and biomedical engineering at New York…
-
Protillion Biosciences Signs Drug Discovery Collaboration with Merck Worth $510 Million
On Jun. 16, 2026, Protillion Biosciences, a leader in lab-in-the-loop AI drug design,announced the signing of a multi-target…
-
Pfizer and China’s Innovent Biologics Enter Global Strategic Collaboration worth $9.85 billion to Accelerate Development of Oncology Medicines
On May 28, 2026, Pfizer and Innovent Biologics announced the companies have entered into a strategic global licensing…
-
Bristol Myers Squibb and Hengrui Pharma Announce Strategic Agreements to Advance Innovative Medicines in Deal Worth $15.2 billion
On May 12, 2026, Bristol Myers Squibb and Hengrui Pharma announced the companies have entered into global strategic…
-
Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera for $2.3 billion in cash
On Apr. 27, 2026, Eli Lilly and Ajax Therapeutics announced a definitive agreement for Lilly to acquire Ajax….
-
Biotechnology | Disease | FDA | Therapeutics
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss
On Apr. 23, 2026, the U.S. Food and Drug Administration (FDA) approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual…
-
Cornell Scientists take big step toward safe, reversible male contraception
On Apr. 7, 2026, Cornell scientists announce they have taken a major step toward developing a safe, reversible,…
-
US measles cases top 1,500 as Texas outbreak grows
On Mar. 27, 2026, measles cases in the United States have climbed to 1,575, with 88 new infections,…
-
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
On Mar. 23, 2026, Pfizer and Valneva announced topline results from the Phase 3 VALOR “Vaccine Against Lyme…
-
Biotechnology | Imaging | NIH | Oncology
Top Computational Biologist Bao Zhirong Returns to Chinese Universities After 30 Years in U.S.
On Feb. 13, 2026, after three decades in the US—from PhD student to full professor—Dr. Bao Zhirong announced…
-
Rising U.S. nonmedical childhood vaccination exemption rates may portend disease resurgence
On Jan. 14, 2026, a Stanford University–led research team estimates that county-level US nonmedical exemptions to childhood vaccine…
-
Mount Sinai Researchers Help Create Largest Immune Cell Atlas of Bone Marrow in Multiple Myeloma Patients
On Jan. 9, 2026, scientists at the Icahn School of Medicine at Mount Sinai, in partnership with the Multiple Myeloma Research…
-
Flu season surged in the U.S. over the holiday and already rivals last winter’s harsh epidemic
On Jan. 5, 2026, U.S. flu infections surged over the holidays, and health officials are calling it a…
-
CRISPR primes goldenberry for fruit bowl fame
On Dec. 19, 2025, Cold Spring Harbor Laboratory (CSHL) plant biologists may have found a “shortcut” to this…
-
Adaptive Inks deals with Pfizer to support research in rheumatoid arthritis and other immune-related diseases woth $890 Million
On Dec. 15, 2025, Adaptive Biotechnologies announced it has signed two non-exclusive deals with Pfizer to support research…
-
Race, Ethnicity and Donor Type Continue to Affect Survival After Donor Stem Cell Transplant
On Dec. 8, 2025, a study led by Roswell Park Comprehensive Cancer Center reveals that a patient’s race…
